By
Latest Stories
Don’t miss our hot and upcoming stories
How Tempus AI and Northwestern Use AI to Unlock the Genomic Code of Alzheimer’s? A New Collaboration Targets Precision Breakthroughs
Key Takeaways Transforming Alzheimer’s Research with AI and Precision GenomicsIn a multi-year collaboration announced today,…
Can Parallel Bio’s $21M Bet on Immune Organoids Cut Drug Failure Rates from 95% to 5%?
Key Highlights Organoid-AI Platform Aims to Transform Preclinical Drug DiscoveryParallel Bio’s proprietary platform replicates the…
Can BullFrog AI and Sygnature Discovery’s $30M Alliance Reshape How Global Biopharma Uses AI in Drug Discovery?
Key Highlights BullFrog AI Secures Global CRO Partner to Scale AI PlatformBullFrog AI has entered…
Can Receptor.AI’s Integration of REAXENSE™ Platform Redefine Full-Stack Drug Discovery?
Key Insights: Advanced Chemistry at ScaleReceptor.AI has incorporated the REAXENSE™ platform, developed by Canada-based Reaxense…